BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25216670)

  • 1. Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness.
    Emdad L; Janjic A; Alzubi MA; Hu B; Santhekadur PK; Menezes ME; Shen XN; Das SK; Sarkar D; Fisher PB
    Neuro Oncol; 2015 Mar; 17(3):419-29. PubMed ID: 25216670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
    Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
    Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2.
    Pan Y; Liang W; Zhao X; Liu L; Qing Y; Li Y
    Neuroreport; 2016 Dec; 27(17):1266-1273. PubMed ID: 27682888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1.
    Wang T; Zhang Y; Cui B; Wang M; Li Y; Gao K
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1394-1403. PubMed ID: 33200790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.
    Shi C; Ren L; Sun C; Yu L; Bian X; Zhou X; Wen Y; Hua D; Zhao S; Luo W; Wang R; Rao C; Wang Q; Yu S
    Br J Cancer; 2017 Sep; 117(7):1036-1047. PubMed ID: 28787434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
    Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
    Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.
    Cui D; Sajan P; Shi J; Shen Y; Wang K; Deng X; Zhou L; Hu P; Gao L
    Oncotarget; 2017 Apr; 8(15):25345-25361. PubMed ID: 28445981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling.
    Huo LW; Wang YF; Bai XB; Zheng HL; Wang MD
    Mol Med; 2020 Apr; 26(1):29. PubMed ID: 32268875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2.
    Yu L; Gui S; Liu Y; Qiu X; Zhang G; Zhang X; Pan J; Fan J; Qi S; Qiu B
    Aging (Albany NY); 2019 Aug; 11(15):5300-5318. PubMed ID: 31386624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
    Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B
    Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-U2AF1 promotes human glioma via derepressing neuro-oncological ventral antigen 2 by sponging hsa-miR-7-5p.
    Li G; Huang M; Cai Y; Yang Y; Sun X; Ke Y
    J Cell Physiol; 2019 Jun; 234(6):9144-9155. PubMed ID: 30341906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1.
    Zheng Y; Lu X; Xu L; Chen Z; Li Q; Yuan J
    Hum Pathol; 2017 Nov; 69():63-71. PubMed ID: 28970140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion.
    Xia Z; Liu F; Zhang J; Liu L
    PLoS One; 2015; 10(7):e0132399. PubMed ID: 26134825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221.
    Santhekadur PK; Das SK; Gredler R; Chen D; Srivastava J; Robertson C; Baldwin AS; Fisher PB; Sarkar D
    J Biol Chem; 2012 Apr; 287(17):13952-8. PubMed ID: 22396537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
    Ma CC; Xiong Z; Zhu GN; Wang C; Zong G; Wang HL; Bian EB; Zhao B
    J Exp Clin Cancer Res; 2016 Jun; 35(1):90. PubMed ID: 27267902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-361-5p inhibits glioma migration and invasion by targeting SND1.
    Liu J; Yang J; Yu L; Rao C; Wang Q; Sun C; Shi C; Hua D; Zhou X; Luo W; Wang R; Li W; Yu S
    Onco Targets Ther; 2018; 11():5239-5252. PubMed ID: 30214229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.